Skip to content

Drug interactions

Fezolinetant + Mexiletine

Severity: Contraindicated

Fezolinetant and Mexiletine: contraindicated interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Fezolinetant is metabolized primarily by CYP1A2, and its exposure rises with CYP1A2 inhibitors. Mexiletine is a CYP1A2 inhibitor, so fezolinetant levels may increase, raising the risk of liver toxicity and other adverse effects. Labeling contraindicates use with CYP1A2 inhibitors.

What this interaction means in plain words

Fezolinetant and Mexiletine are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two.

Fezolinetant belongs to Endocrine; Mexiletine belongs to Cardiovascular.

Evidence level: Moderate

Why it happens

Mexiletine inhibits CYP1A2, reducing fezolinetant clearance.

What to do

Do not use together; choose another menopause vasomotor therapy. If mexiletine is required, stop fezolinetant.

What to ask your pharmacist

  • Is there an alternative to one of these two medicines for me?
  • If both are essential, who is monitoring me and how often?
  • Which symptoms mean I should stop and seek help straight away?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Fezolinetant and Mexiletine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Fezolinetant with Mexiletine?

MediHelp rates the interaction as contraindicated. Fezolinetant and Mexiletine are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two. Fezolinetant is metabolized primarily by CYP1A2, and its exposure rises with CYP1A2 inhibitors. Mexiletine is a CYP1A2 inhibitor, so fezolinetant levels may increase, raising the risk of liver toxicity and other adverse effects. Labeling contraindicates use with CYP1A2 inhibitors.

How serious is the interaction between Fezolinetant and Mexiletine?

MediHelp rates it contraindicated, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Do not use together; choose another menopause vasomotor therapy. If mexiletine is required, stop fezolinetant.

What other medicines interact with Mexiletine?

MediHelp also lists interactions of Mexiletine with, for example, Pimozide, Alosetron, Amiodarone. The full list is on the Mexiletine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in